Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Parkinson's Disease

Free Subscription 23.03.2026 2 Ann Neurol 2 BMC Neurol 1 Exp Neurol 2 J Neural Transm (Vienna) 5 Mov Disord 1 Nat Med 1 Nat Rev Neurol 3 Neurology 1 Neurosci Lett 5 PLoS One 3 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. TROPEA TF, Stevenson PA, Flitter M, Meehan D, et al
   Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease.
   Ann Neurol. 2026 Mar 18. doi: 10.1002/ana.78201.
   PubMed         Abstract available
   
   
2. ONO D, Sekiya H, Maier AR, Graff-Radford NR, et al
   Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism.
   Ann Neurol. 2026 Mar 14. doi: 10.1002/ana.78193.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. WALI GM, Wali G
   Slow motion videography in Parkinson's disease: unraveling masked phenomenology.
   BMC Neurol. 2026 Mar 17. doi: 10.1186/s12883-026-04808.
   PubMed        
   
   
4. SHOEIBI A, Shariati-Moghaddam R, Ahmad MA, Ostadimoghaddam H, et al
   Comparative study of refractive errors between patients with Parkinson's disease versus age- and sex-matched healthy controls.
   BMC Neurol. 2026 Mar 16. doi: 10.1186/s12883-026-04822.
   PubMed        
   
   

   
   Exp Neurol

5. ANAYYAT U, Mei X, Zhang F, Yi R, et al
   Neuroprotective effect of RMF in a mouse model of sporadic Parkinson's disease.
   Exp Neurol. 2026 Mar 18:115738. doi: 10.1016/j.expneurol.2026.115738.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

6. MAEDA T, Mizutani Y, Ohdake R, Nagao R, et al
   Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation.
   J Neural Transm (Vienna). 2026;133:485-494.
   PubMed         Abstract available
   
   
7. LEAVITT VM, Simani L, Haghighi AB, Koch M, et al
   Language dysfunction as a primary feature of cognitive decline in neurological populations.
   J Neural Transm (Vienna). 2026;133:397-407.
   PubMed         Abstract available
   
   

   
   Mov Disord

8. FOLKE J, DellaValle B, Jorgensen ML, Mogensen PB, et al
   Diagnostic Value of Glycocalyx Shedding in Blood for Differentiating between Parkinson's Disease and Multiple System Atrophy.
   Mov Disord. 2026 Mar 19. doi: 10.1002/mds.70274.
   PubMed         Abstract available
   
   
9. HELY M
   The Sydney Multicenter Study of Parkinson's Disease: The Why, the How, and the Outcome.
   Mov Disord. 2026 Mar 17. doi: 10.1002/mds.70245.
   PubMed        
   
   
10. SALARI M, Etemadifar M, Soleimani S
    Parkinson's Disease in Times of War: Gaps in Knowledge and Emerging Controversies.
    Mov Disord. 2026 Mar 17. doi: 10.1002/mds.70272.
    PubMed         Abstract available
    
    
11. FULLER RLM, Monje MHG, Chahine LM, Delgado EC, et al
    International Parkinson and Movement Disorder Society Clinical Outcome Assessments are Available in REDCap.
    Mov Disord. 2026 Mar 16. doi: 10.1002/mds.70224.
    PubMed        
    
    
12. DING H, Xie K, Bange M, Kuhne H, et al
    Macroscale Gradient-Informed Neural Oscillation Topography in Parkinson's Disease.
    Mov Disord. 2026 Mar 16. doi: 10.1002/mds.70277.
    PubMed         Abstract available
    
    

    
    Nat Med

13. BOLSEWIG K, Bellomo G, Hok-A-Hin YS, Al Idrissi I, et al
    A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.
    Nat Med. 2026;32:1073-1084.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

14. FYFE I
    Gut macrophages involved in Parkinson disease pathogenesis.
    Nat Rev Neurol. 2026 Mar 18. doi: 10.1038/s41582-026-01198.
    PubMed        
    
    

    
    Neurology

15. DIAZ-GALVAN P, Franco-Rosado P, Silva-Rodriguez J, Castro-Labrador S, et al
    Association of Physical Exercise With Structural Brain Changes and Cognitive Decline in Patients With Early Parkinson Disease.
    Neurology. 2026;106:e214947.
    PubMed        
    
    
16. NIEMI KJ, Jaakkola E, Myller EM, Eklund MRE, et al
    Striatal Dopamine Transporter and Rest Tremor in Parkinson Disease: A Clinical Validation.
    Neurology. 2026;106:e214811.
    PubMed         Abstract available
    
    
17. SUPER M, Paul RA, Irwin DJ, Aamodt WW, et al
    Teaching Video NeuroImage: C9orf72-Related Parkinsonism.
    Neurology. 2026;106:e214828.
    PubMed        
    
    

    
    Neurosci Lett

18. TOBIN ER, Ofori E, McClure SM, Mehta SH, et al
    Associating Resting-State functional connectivity and improvements in reactive balance in Parkinson's Disease.
    Neurosci Lett. 2026 Mar 18:138584. doi: 10.1016/j.neulet.2026.138584.
    PubMed         Abstract available
    
    

    
    PLoS One

19. ZUO M, Li J, Chang M, Zhang Q, et al
    Robust 3D Pose estimation and Parkinson's Disease classification via Dual-Stage Adaptive Temporal Perception and graph topology modeling network.
    PLoS One. 2026;21:e0344375.
    PubMed         Abstract available
    
    
20. KANG K, Arakawa R, Sterner I, Seemiller J, et al
    Effect of rhythmic auditory stimulation (RAS)(R) with and without melody on Parkinson's disease (PD) patients with deep brain stimulation (DBS): A study protocol.
    PLoS One. 2026;21:e0344290.
    PubMed         Abstract available
    
    
21. KUNUGITANI K, Sawamura M, Taguchi T, Hirato T, et al
    Evaluation of a commercial AI-assisted cell counting software for dopaminergic neurons across species.
    PLoS One. 2026;21:e0344621.
    PubMed         Abstract available
    
    
22. MORCILLO-MARTINEZ L, Sanz-Marmol M, Romanos-Navarrete AI, Calvo S, et al
    Effects of a level-based immersive virtual reality physical therapy program on static and dynamic balance in Parkinson's disease: Protocol for a randomized controlled trial.
    PLoS One. 2026;21:e0344457.
    PubMed         Abstract available
    
    
23. ZANATTA F, Steca P, Fundaro C, Giardini A, et al
    Longitudinal evidence of technology-enhanced, individualized neuromotor rehabilitation on autonomy, cognition, quality of life, and psychological well-being: Pilot multi-sample study.
    PLoS One. 2026;21:e0344472.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. HASSANZADEH K, Liu J, Zhang J, Tabari MA, et al
    The cross-linking activity of transglutaminase 2 drives alpha-Synuclein pathology in synucleinopathy models.
    Proc Natl Acad Sci U S A. 2026;123:e2517886123.
    PubMed         Abstract available
    
    
25. ZOU Z, Zhou J, Lu Y, Huang Y, et al
    ATP13A2 restrains macrophage NLRP3 inflammasome activation to repress neurodegeneration via modulating mitochondrial homeostasis.
    Proc Natl Acad Sci U S A. 2026;123:e2534066123.
    PubMed         Abstract available
    
    
26. LIM CM, Vendruscolo M
    The alpha-synuclein proteostasis network and its translational applications in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2513317123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum